Insulin has been shown to have anti-natriuretic actions in humans and animal models.
-labeled insulin, demonstrated binding sites in multiple cell types along the renal tubular epithelium. However, because the kidney expresses other receptors similar to the classical insulin receptor (IR), including the insulin growth factor receptor (IGF) and the insulin-receptor-related receptor (IRR), the precise nature of the "receptor" that labeled insulin was binding to wasn't absolutely certain. Nonetheless, more recent studies showed mRNA expression of the classic IR in whole homogenates of the kidney (31, 32, 130, 132); and our group (150) has recently found IR expression at the protein level using immunoblotting and immunohistochemistry in proximal tubule, thick ascending limb, and collecting duct. In this review, we discuss studies that have investigated the regulation of the major renal sodium transporters in the kidney by insulin. In addition, we examine how this regulation is altered in insulin resistance, which is a hyperinsulinemic state, as well as in type I and type II diabetes. We also discuss what is known about the regulation of the IR in the kidney, how it is affected by insulin resistance and/or diabetes, and how this might ultimately affect sodium balance and blood pressure.
Localization of the insulin receptor (IR) in kidney
The insulin receptor (IR) in metabolic tissues such as liver, adipose, and muscle has been extensively studied; however its role in the kidney is less well defined. The human IR cDNA was first cloned and reported in 1985 (43, 154) . The characterization of the cDNA clones encoding IR indicated that the receptor is composed of two subunits, i.e., and , which are derived by the proteolytic processing of a 1382 amino-acid long Page 3 of 48 pre-proreceptor. Subsequently, the exon-intron organization of the human IR gene and characterization of the 5' flanking promoter sequence, that regulate its expression, was determined by Sieno et al (133) .. They have shown that the IR gene spans more than 120 kb and is encoded by 22 exons and 21 introns. Exon 11 is subjected to alternative splicing leading to two isoforms, A and B, which differ in their affinity for insulin with B being higher than the A isoform. Furthermore, they have also determined that there are three transcriptional initiation sites and an active promoter region that lacks the TATAlike sequence. IR is a member of the receptor tyrosine kinase super-family. Thesubunit is primarily extracellular and contains the ligand-binding domain whereas thesubunit is intrinsic to the lipid bilayer and contains the tyrosine kinase signaling domain, which catalyses the transfer of the phosphate of ATP to tyrosine residues on protein Sechi and associates utilized an autoradiographic technique with membrane preparations obtained from both glomeruli and tubules of the rat kidney (127) . In the cortex, binding density was comparable in glomeruli and tubules. In the medulla, bound radioligand was found primarily in longitudinal structures traversing the outer portion, presumably corresponding to vascular bundles, and in the inner portion. Butlen et al. 
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They demonstrated that renal insulin receptors in chicken are up-regulated by fasting and down-regulated by refeeding. We recently localized the IR in rat kidney using immunofluoresence and commercially available polyclonal antibodies against the -and -subunits (150) . These antibodies were designed not to overlap with receptors of similar structure also expressed in the kidney including the insulin-like growth factor receptor (IGF1) and the insulin-receptor-related receptor (IRR) found in renal intercalated cells (8, 115) . We found that classic IR was expressed in proximal tubule, TAL, distal convoluted tubule, and CD.
Regulation of sodium transport proteins along the renal tubule by insulin
Based on the expression pattern of IR, it is not surprising to find that insulin increases the sodium reabsorptive activity of major renal sodium transporter proteins in nearly every cell type that reabsorbs NaCl, from the proximal tubule throughout the collecting duct (19, 49-51, 54, 60, 96, 100, 117).
Proximal tubule (PT): Two decades ago, Baum (9) demonstrated that insulin added to the bath increased J v (volume flux) in isolated perfused proximal tubules from rabbit kidney. This suggested insulin directly stimulated sodium reabsorption in this segment. The regulation of a variety of major sodium transporters and exchangers in proximal tubule by insulin has been examined. First of all, the sodium hydrogen exchanger, type III (NHE3) is responsible for about 60-65% of the apical sodium reabsorption in the proximal tubule, which as a segment is responsible for reabsorbing about 65% of the total filtered sodium load (157) . Thus, regulation of NHE3 activity, if not compensated for downstream, has the potential to greatly affect overall sodium balance. Insulin has been shown to increase NHE3 activity both acutely and chronically in a cell line derived from opossum kidney with proximal tubule like characteristics (OKP Recently, this same group reported that the mechanism for chronic induction involved activation of phosphatidylinositol 3-kinase (PI-3K) and serum and glucocorticoid-regulated kinase 1 (SGK1), as transport was inhibitable by wortmannin, a PI-3K antagonist, or co-expression of dominant-negative SGK1(60).
Insulin has also been shown to be anti-phosphaturic (36). The major tubule segment responsible for the regulation of phosphorus reabsorption in the kidney is the proximal tubule. The sodium phosphate cotransporter, type II (NaPi-2) is responsible for apical phosphorus reabsorption coupled to sodium in the proximal tubule (14). In 1984,
Hammerman et al. showed insulin-mediated increased phosphate uptake by isolated renal proximal tubule brush border from dog kidney (69). In later studies performed in OKP cells, the increased reabsorptive activity due to insulin was demonstrated to be influenced by calcium, as active transport was facilitated by the calcium channel blockers, verapamil and nifedipine (1) . Increased phosphate reabsorption by NaPi-2 would simultaneously increase sodium reabsorption in the proximal tubule given no changes in other apical transporter activity.
Feraille and associates have performed many elegant studies demonstrating and characterizing the ability of insulin to activate the basolateral sodium potassium adenosine triphosphatase (Na-K-ATPase) (50-54). This pump is essential in establishing the electrochemical gradient for sodium reabsorption in all cells of the renal tubule that reabsorb NaCl. In proximal tubule suspensions from rats, as well as in microdissected tubules, activation appears to involve phosphorylation of a tyrosine residue on the -subunit of Na-K-ATPase (52).
Thick ascending limb (TAL): TAL is critical in determining water concentrating and diluting capacity of the kidney, but may also affect sodium balance (157 phosphorylation occurred on all 3 subunits and was associated with increased activity (169) . Figure 2 illustrates how insulin might increase sodium reabsorption in the collecting duct principal cell by activating both ENaC and Na-K-ATPase.
Altered expression of sodium transporter and channels in diabetes
An absence of circulating insulin or a substantial decrease in the activity of insulin at the cell level leads to impaired glucose uptake from plasma, hyperglycemia, and glucosuria, i.e., diabetes mellitus. Type I diabetes mellitus is due to the destruction of insulin producing K-cells in the pancreatic islets. It is primarily a T-cell mediated autoimmune disease directed against a K-cell auto-antigen (101) . In humans, this is treated with various cocktails of insulin that are designed to release slowly or quickly to try to mimic endogenous patterns. However, this regulation is clearly not perfect and periods of hyper-and hypoglycemia develop. A major portion of the morbidity and mortality arising from diabetes mellitus is due to the high incidence of progressive kidney dysfunction and diabetic nephropathy.
Type I diabetes has been associated with natriuresis and diuresis, as well as, activation of vasopressin and the renin-angiotensin-aldosterone system (RAAS) (7, 84). replacement to ovariectomized (OVX) female rats in the setting of STZ-induced diabetes on the expression of sodium transport proteins. E 2 replacement in STZ-diabetic rats altered the ratio of estrogen receptor subtypes in the kidney (164), and also, attenuated the severity of the diabetes, as measured by a reduction in the hyperglycemia in these rats (124). With regard to changes in transport proteins, NKCC2 abundance was increased by diabetes in the whole kidney and outer medulla, as in our earlier short-term (4-day) study described previously (142) . E 2 replacement normalized NKCC2 expression. Similarly, E 2 replacement normalized the expression of L-and K-ENaC, which were reduced in diabetic female rats. Decreased L-and K-ENaC in the chronically diabetic female rats contrasted with our earlier finding in the male rats, which were diabetic for only 4 days (142) . The reasons underlying these discrepancies are not clear. It is possible that the sex of the rats modulates these responses, or that the differing lengths of the two studies played a role. In other words, the ability to compensate with upregulation of all distal proteins may be compromised long-term.
Finally, in this chronic study on female rats, we also saw increased NHE3 and decreased NaPi-2 protein levels in the STZ-treated rats (124). E 2 replacement reduced the abundance of NHE3, but did not restore the abundance of NaPi-2. Thus, estrogen status is clearly modulatory with regard to the regulation of major sodium transport proteins in the STZ-induced diabetic rat. The cellular mechanisms underlying the up or down-regulation of specific transporters, and whether insulin or insulin signaling plays a role, is in need of further study.
In contrast to type I, in type II diabetes (non-insulin dependent diabetes mellitus), circulating plasma insulin levels may be high, normal, or low depending on how advanced pancreatic -cell exhaustion has progressed. Type II diabetes is an expanding problem worldwide, and is the manifestation of extreme insulin resistance.
"Insulin resistance" refers to blunted insulin receptor (IR) signaling in the major metabolic tissues including liver, adipose, and skeletal muscle to a given level of circulating insulin, and is commonly associated with obesity. Approximately 40% of the patients with type II diabetes will develop diabetic kidney disease (99). Many animal models of type II diabetes have been used to examine metabolic abnormalities and diabetic complications including, the ob/ob mouse (leptin deficient), the db/db mouse (leptin receptor deficient) (6), the non-obese Goto Kakizaki rat (153, 168) , the obesity-prone Sprague-Dawley rat (38-40), the diabetic Zucker rat (70), and the obese Zucker rat (77). The diabetic Zucker rat is a substrain of the obese Zucker rat (leptin receptor mutation), and develop diabetes at a fairly young age (156 of Na-K-ATPase, NCC, and -ENaC. When we examined slightly older (6-month-old), overtly diabetic obese Zucker rats, the renal sodium transporter profile was remarkably altered (15). In these rats, we found a marked decrease in several proximal tubule, thick ascending limb, and collecting duct apical sodium transporters or channel subunits including NKCC2, L-ENaC, NHE3, and NaPi-2 relative to lean age-mates. Thus, these proteins may be sensitive to factors relating to the diabetes and/or nephropathy, but not strictly to insulin resistance.
In agreement with our findings in young Zucker rats, Lokhandwala, Hussain and colleagues (74) demonstrated increased activity of Na-K-ATPase, and also NHE3 in (NaPi-2) abundance, but decreased NKCC2, and no change in ENaC subunits, NCC, NHE3, or L1-Na-K-ATPase in Sprague-Dawley rats.
The Dahl salt-sensitive rat is also insulin resistant (151), as are Ang II-infused rats (111), and high-NaCl fed rats (112) . The cellular mechanisms underlying insulin sensitivity in these models are not well understood, but have been proposed to involve later components of IR signaling, i.e., post PI-3K activation, perhaps involving increased oxidative stress (113) . No studies, to our knowledge have examined IR signaling in the kidney in these models.
Insulin and blood pressure
Hyperinsulinemia, as a result of insulin resistance, is clearly associated with hypertension in humans and animal models (23, 42, 55, 83). However, whether increased insulin signaling in any tissue is the cause of increased blood pressure is uncertain. Moreover, the effects of insulin infusion on blood pressure and hemodynamics in general, in mammals, are variable. Hall, Brands and colleagues (26) demonstrated over 15 years ago, that insulin infusion into rats increases blood pressure.
The rise in blood pressure was not associated with any sustained increase in sodium balance, but did correspond to a transient fall in glomerular filtration rate (GFR). They went on to pursue the mechanism for these effects and subsequently reported that hyperinsulinemia, in the rat, was not salt-sensitive, but led to a right-ward shift in the pressure-natriuretic curve as sodium balance was maintained at a higher blood pressure (25). They (87) found no evidence for increased adrenergic activity as blockade of either pressure rise. On the contrary, thromboxane and an intact renin-angiotensin system (RAS) were found to be important in mediating the rise in blood pressure in the rat. A thromoboxane synthesis inhibitor, U63557A (87) or co-infusion with an angiotensin converting enzyme (ACE) inhibitor (24) significantly attenuated the rise in blood pressure and fall in GFR.
Other investigators (45, 106) including ourselves (140) have confirmed the rise in blood pressure in rats with insulin infusion (Figure 4) . We (140) found the rise in blood pressure using radiotelemetry, was associated with increased natriuretic response to benzamil and hydrochlorothiazide and increased apical localization of ENaC subunits in rat kidney, as described above. Edwards et al. (45) found increased blood pressure in rats infused with insulin, was blockable by chemical denervation. Meehan et al. (106) demonstrated that the rise in blood pressure and heart rate in rats infused with insulin was preventable by co-infusion with the sympatholytic agent, clonidine.
To the contrary, insulin infusion into mixed-breed dogs using a similar approach does not appear to increase blood pressure, even when renal mass is reduced (27, 68).
In the dogs, insulin did, however result in peripheral vasodilatation leading to reduced peripheral vascular resistance, as well as, sodium retention (27). Few studies have reported the effects of insulin infusion into mice. Huang et al. (71) reported that acute insulin infusion into mice on a mixed Sv129/C57Bl background did not raise blood pressure or alter GFR, but it did produce anti-natriuresis. Insulin infusion into human subjects, normal or with borderline hypertension has been reported to raise (88, 125), decrease (3), or not change mean arterial blood pressure (11, 63, 110). It is likely that species/strain or underlying conditional differences in blood pressure response to insulin infusion reflect the fact that insulin signaling is associated both with factors that may reduce blood pressure, e.g., nitric oxide generation and factors that may increase blood pressure, e.g., increased sodium reabsorption, activation of the sympathetic nervous system, augmentation of the RAS and/or thromboxane synthesis. Ultimately, insulin may be viewed as more of a facilitator rather than a cause of increased blood pressure and clearly dependent on other factors. This facilitation, however, may be particularly important in disease states such as insulin resistance, type II diabetes, and obesity.
Insulin resistance and blood pressure
It is fairly clear that insulin resistance in humans and animals models is associated with hypertension. Insulin resistance, however, is clearly a complex disorder and the role of hyperinsulinemia, per se, on blood pressure control in the context of other metabolic disturbances is uncertain. One problem is that it is difficult to alleviate the hyperinsulinemia without affecting other metabolic parameters. We (89) showed that treatment of young obese Zucker rats the PPAR-agonist, rosiglitazone (RGZ), normalized blood pressure for nearly the entire 12-week study. Treatment with RGZ also markedly reduced circulating insulin levels. However, RGZ also reduced plasma triglycerides and urine albumin excretion. Thus, we clearly cannot ascribe the normalization in blood pressure to solely to the fall in circulating insulin levels in this complex disease model. However, it did seem to relate, overall to the amelioration of the insulin-resistant state in these rats. These findings were in agreement with those of Increased expression levels of both receptors may increase the sensitivity of obese rats Nonetheless, not all researchers have found that a diet high in fructose raises blood pressure in normal rats (12, 22, 33, 141). Brands et al. saw no effect of fructose on blood pressure after 11 days in Sprague-Dawley rats (22). We also saw little effect of fructose to raise blood pressure in Sprague-Dawley rats even when coupled with highNaCl or high-fat, which did tend to marginally raise blood pressure (141) . In our study, a high fructose diet did increase kidney size and raise plasma triglycerides (141) . One difference between the latter studies and many of the McNeill studies is that tail-cuff measurements were made in the former and direct arteriography or radiotelemetry was used in the latter cases. The act of performing tail-cuff plethysmography even in trained rats is likely stimulating and may raise blood pressure in susceptible animals. We might speculate that fructose-feeding makes these animals more sensitive with regard to blood pressure response to small stressors such as routine tail cuff measurements that might increase sympathetic activity.
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Therefore, in the case of insulin resistance with high circulating plasma insulin levels, often 10 times higher than normal levels (16), it is not clear whether it is increased IR signaling, decreased or neither which increases blood pressure.
Furthermore, while insulin resistance is clearly associated with impaired IR signaling in major metabolic tissues, signaling in the kidney, the organ perhaps most critical in blood pressure regulation, has not been well defined.
The renal insulin receptor (IR): altered regulation in diabetes, role in blood pressure control
The etiology of insulin-resistance has not been definitively elucidated, but most studies agree that reduced IR signaling relative to circulating insulin levels, is decidedly a key determinant (56). Down-regulation of the level of IR protein itself, with insulinresistance, has been demonstrated in various insulin-target tissues central to energy metabolism, e.g., liver, skeletal muscle, and adipose tissue (21, 64, 159), but not specifically in kidney. We have recently found reduced IR protein in the kidney of obese Zucker rats and rats fed a high-fat diet for several weeks, relative to respective controls (147, 150) . The reduction occurred in both subunits and the intensity tended to be correlated with the severity of the insulin resistance. The inner medulla appeared to be the most sensitive to insulin-resistance associated down regulation. Immunoperoxidase labeling of IR-revealed that the down-regulation in the inner medulla was associated with CD cells. We suggest this down-regulation could impact the regulation of CD proteins such as ENaC, Na-K-ATPase, and possibly even aquaporin 2 (AQP2). Downregulation of CD IR might also affect nitric oxide (NO) generation in this cell type; insulin has been shown to increase NO in many tissues (143) . Collecting duct nitric oxide synthase (NOS) activity has been shown to be among the highest relative to other renal segments (166) . Furthermore, all three isoforms, neuronal-, endothelial-, and inducible- In contrast, Sechi, Catena and colleagues determined that while IR binding and mRNA in the liver and skeletal muscle was decreased in fructose-fed, insulin-resistant rats, there was no difference in the kidney, as compared to control rats (31, 32, 127, 130). Similarly, corticosterone-induced insulin resistance in chicken could not change the renal insulin receptors numbers, affinity or tyrosine kinase activity (18). Therefore, they suggested that the relative absence of renal "insulin-resistance" would allow for the greater circulating levels of insulin to bind to renal IR and increase, e.g., sodium reabsorption and therefore, blood pressure. Furthermore, based on mRNA expression and insulin binding studies, Sechi's group (129, 132) also reported increased renal IR in streptozotocin-induced diabetic rats, and, in this context, IR binding remained unaffected by angiotensin II levels.
Moreover, Sechi and colleagues demonstrated that both the density and level of mRNA encoding IRs in the kidney are inversely related to the dietary sodium content, by using in situ autoradiography and mRNA analysis (31, 128, 130, 131) ( Figure 5 ). Based on these findings, they suggest that this reduced IR is a feedback mechanism that limits the insulin-induced sodium retention when extracellular fluid volume is expanded.
Furthermore they have also demonstrated that this feedback mechanism is lost in fructose-fed Sprague-Dawley rats (32) and also in Spontaneously Hypertensive Rats (SHR) (128) . This abnormality might be implicated in the pathophysiology of insulin resistance and hypertension in these models. However, this inverse relation between salt intake and renal IR could not be found in the mildly insulin resistant Dahl saltsensitive rat (131) . Currently we are developing several renal cell selective knockouts of the IR; and phenotyping is ongoing (146, 148) . The generation of these renal epithelial cell specific knockouts of IR will allow us to further elucidate the role of the IR in the kidney and more broadly to derive insight into the mechanism(s) underlying with insulin-resistanceassociated hypertension.
Conclusions
Overall, insulin actions on renal epithelial cells are ubiquitous and likely play a more important role in the physiologic control of nutrient reabsorption and blood pressure than currently appreciated. Insulin levels vary throughout the day with meals Normal regulation of renal salt, water, and other nutrient reabsorption might be expected to be altered in these individuals. However, how the insulin receptor signals in this context and the resulting impact on physiology such as blood pressure control has not been sufficiently elucidated. Further studies are warranted to evaluate the regulation of insulin signaling in the kidney in health, obesity, and diabetes.
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